Top Markets
#1 Orochi Network Orochi Network +71.79%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +24.63%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 Cheems Token Cheems Token +14.21%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rangering i aksjer #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aksjekurs
$50.95
Markedsverdi
$226.41B
Endring (1 dag)
2.58%
Endring (1 år)
-26.16%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategori

Healthcare
Driftsmargin for Novo Nordisk A/S (NVO)
Driftsmargin per July 2026 TTM: 45.30%
Ifølge Novo Nordisk A/S sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 45.30%. Ved slutten av 2024 hadde selskapet en driftsmargin på 44.19%.
Historikk for driftsmargin for Novo Nordisk A/S fra 2000 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) 45.30% 9.42%
2025 41.40% -6.31%
2024 44.19% 0.07%
2023 44.16% 4.45%
2022 42.28% 1.51%
2021 41.65% -2.32%
2020 42.64% -0.86%
2019 43.01% 1.80%
2018 42.25% -3.63%
2017 43.84% 1.18%
2016 43.33% -5.41%
2015 45.81% 17.95%
2014 38.84% 3.08%
2013 37.68% -0.24%
2012 37.77% 12.01%
2011 33.72% 8.49%
2010 31.08% 6.29%
2009 29.24% 7.66%
2008 27.16% 27.03%
2007 21.38% -9.14%
2006 23.53% -1.75%
2005 23.95% -0.42%
2004 24.05% -0.04%
2003 24.06% 1.31%
2002 23.75% 0.64%
2001 23.60% 15.74%
2000 20.39% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -99.14%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.32% -99.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -99.44%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -99.43%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
17.54% -99.61%
US
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.